These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 12532564
1. [Cholestasis from ticlopidine: two clinical cases]. Varvello L, Arnò C, Coggiola M, Ramassotto E, Pascale C. Ann Ital Med Int; 2002; 17(4):252-5. PubMed ID: 12532564 [Abstract] [Full Text] [Related]
2. [2 cases of acute cholestasis caused by ticlopidine]. Guzzini F, Banfi L, Gomitoni A, Marchegiani C, Novati P, Mesina M, Frigerio B. Recenti Prog Med; 1997 Mar; 88(3):124-7. PubMed ID: 9173469 [Abstract] [Full Text] [Related]
7. Drug-induced vanishing bile duct syndrome: response to ursodiol. O'Brien CB, Shields DS, Saul SH, Reddy KR. Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017 [No Abstract] [Full Text] [Related]
8. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report]. Lengyel G, Fehér R, Gardó S, Fehér J. Orv Hetil; 2002 Dec 29; 143(52):2885-8. PubMed ID: 12638316 [Abstract] [Full Text] [Related]
10. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Kondrackiene J, Beuers U, Kupcinskas L. Gastroenterology; 2005 Sep 29; 129(3):894-901. PubMed ID: 16143129 [Abstract] [Full Text] [Related]
14. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases. Berkane N, Cocheton JJ, Brehier D, Merviel P, Wolf C, Lefèvre G, Uzan S. Acta Obstet Gynecol Scand; 2000 Nov 29; 79(11):941-6. PubMed ID: 11081677 [Abstract] [Full Text] [Related]
15. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR. Arch Dermatol; 2007 Jun 29; 143(6):757-62. PubMed ID: 17576942 [Abstract] [Full Text] [Related]
17. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid. Tromm A, May B, Klein CG, Klein R, Fisseler-Eckhoff A, Griga T. Hepatogastroenterology; 2005 Jun 29; 52(63):753-6. PubMed ID: 15966198 [Abstract] [Full Text] [Related]
18. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients. George R, Stevens A, Berkenbosch JW, Turpin J, Tobias J. South Med J; 2002 Nov 29; 95(11):1276-9. PubMed ID: 12539993 [Abstract] [Full Text] [Related]
19. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid]. Garzón L, Ledo A, Cubells E, Sáenz P, Vento M. An Pediatr (Barc); 2009 Jun 29; 70(6):547-52. PubMed ID: 19443280 [Abstract] [Full Text] [Related]